Cargando…
KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation
BACKGROUND: KLF5 is a basic transcriptional factor that regulates multiple physiopathological processes. Our recent study showed that deletion of Klf5 in mouse prostate promotes tumorigenesis initiated by the deletion of Pten. While molecular characterization of Klf5-null tumors suggested that angio...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417294/ https://www.ncbi.nlm.nih.gov/pubmed/25896712 http://dx.doi.org/10.1186/s12943-015-0365-6 |
_version_ | 1782369350779404288 |
---|---|
author | Ci, Xinpei Xing, Changsheng Zhang, Baotong Zhang, Zhiqian Ni, Jenny Jianping Zhou, Wei Dong, Jin-Tang |
author_facet | Ci, Xinpei Xing, Changsheng Zhang, Baotong Zhang, Zhiqian Ni, Jenny Jianping Zhou, Wei Dong, Jin-Tang |
author_sort | Ci, Xinpei |
collection | PubMed |
description | BACKGROUND: KLF5 is a basic transcriptional factor that regulates multiple physiopathological processes. Our recent study showed that deletion of Klf5 in mouse prostate promotes tumorigenesis initiated by the deletion of Pten. While molecular characterization of Klf5-null tumors suggested that angiogenesis was partially responsible for tumor promotion, the precise function and mechanism of KLF5 deletion in prostate tumor angiogenesis remain unclear. RESULTS: Applying histological staining to Pten-null mouse prostates, we observed that deletion of Klf5 significantly increased the number of microvessels, accompanied by the upregulation of multiple angiogenesis-related genes based on microarray analysis with MetaCore software. In human umbilical vein endothelial cells (HuVECs), tube formation and migration, both of which are indicators of angiogenic activities, were decreased by conditioned media from PC-3 and DU 145 human prostate cancer cells with KLF5 overexpression, but increased by media from cells with KLF5 knockdown. HIF1α, a key angiogenesis inducer, was upregulated by KLF5 loss at the protein but not the mRNA level in both mouse tissues and human cell lines, as determined by immunohistochemical staining, real-time RT-PCR and Western blotting. Consistently, KLF5 loss also upregulated VEGF and PDGF, two pro-angiogenic mediators of HIF1α function, as analyzed by immunohistochemical staining in mouse tissues and ELISA in conditioned media. Mechanistically, AKT activity, which caused the accumulation of HIF1α, was increased by KLF5 knockout or knockdown but decreased by KLF5 overexpression. PI3K/AKT inhibitors consistently abolished the effects of KLF5 knockdown on angiogenic activity, HIF1α accumulation, and VEGF and PDGF expression. CONCLUSION: KLF5 loss enhances tumor angiogenesis by attenuating PI3K/AKT signaling and subsequent accumulation of HIF1α in PTEN deficient prostate tumors. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-015-0365-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4417294 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44172942015-05-03 KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation Ci, Xinpei Xing, Changsheng Zhang, Baotong Zhang, Zhiqian Ni, Jenny Jianping Zhou, Wei Dong, Jin-Tang Mol Cancer Research BACKGROUND: KLF5 is a basic transcriptional factor that regulates multiple physiopathological processes. Our recent study showed that deletion of Klf5 in mouse prostate promotes tumorigenesis initiated by the deletion of Pten. While molecular characterization of Klf5-null tumors suggested that angiogenesis was partially responsible for tumor promotion, the precise function and mechanism of KLF5 deletion in prostate tumor angiogenesis remain unclear. RESULTS: Applying histological staining to Pten-null mouse prostates, we observed that deletion of Klf5 significantly increased the number of microvessels, accompanied by the upregulation of multiple angiogenesis-related genes based on microarray analysis with MetaCore software. In human umbilical vein endothelial cells (HuVECs), tube formation and migration, both of which are indicators of angiogenic activities, were decreased by conditioned media from PC-3 and DU 145 human prostate cancer cells with KLF5 overexpression, but increased by media from cells with KLF5 knockdown. HIF1α, a key angiogenesis inducer, was upregulated by KLF5 loss at the protein but not the mRNA level in both mouse tissues and human cell lines, as determined by immunohistochemical staining, real-time RT-PCR and Western blotting. Consistently, KLF5 loss also upregulated VEGF and PDGF, two pro-angiogenic mediators of HIF1α function, as analyzed by immunohistochemical staining in mouse tissues and ELISA in conditioned media. Mechanistically, AKT activity, which caused the accumulation of HIF1α, was increased by KLF5 knockout or knockdown but decreased by KLF5 overexpression. PI3K/AKT inhibitors consistently abolished the effects of KLF5 knockdown on angiogenic activity, HIF1α accumulation, and VEGF and PDGF expression. CONCLUSION: KLF5 loss enhances tumor angiogenesis by attenuating PI3K/AKT signaling and subsequent accumulation of HIF1α in PTEN deficient prostate tumors. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-015-0365-6) contains supplementary material, which is available to authorized users. BioMed Central 2015-04-21 /pmc/articles/PMC4417294/ /pubmed/25896712 http://dx.doi.org/10.1186/s12943-015-0365-6 Text en © Dong et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Ci, Xinpei Xing, Changsheng Zhang, Baotong Zhang, Zhiqian Ni, Jenny Jianping Zhou, Wei Dong, Jin-Tang KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation |
title | KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation |
title_full | KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation |
title_fullStr | KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation |
title_full_unstemmed | KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation |
title_short | KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation |
title_sort | klf5 inhibits angiogenesis in pten-deficient prostate cancer by attenuating akt activation and subsequent hif1α accumulation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417294/ https://www.ncbi.nlm.nih.gov/pubmed/25896712 http://dx.doi.org/10.1186/s12943-015-0365-6 |
work_keys_str_mv | AT cixinpei klf5inhibitsangiogenesisinptendeficientprostatecancerbyattenuatingaktactivationandsubsequenthif1aaccumulation AT xingchangsheng klf5inhibitsangiogenesisinptendeficientprostatecancerbyattenuatingaktactivationandsubsequenthif1aaccumulation AT zhangbaotong klf5inhibitsangiogenesisinptendeficientprostatecancerbyattenuatingaktactivationandsubsequenthif1aaccumulation AT zhangzhiqian klf5inhibitsangiogenesisinptendeficientprostatecancerbyattenuatingaktactivationandsubsequenthif1aaccumulation AT nijennyjianping klf5inhibitsangiogenesisinptendeficientprostatecancerbyattenuatingaktactivationandsubsequenthif1aaccumulation AT zhouwei klf5inhibitsangiogenesisinptendeficientprostatecancerbyattenuatingaktactivationandsubsequenthif1aaccumulation AT dongjintang klf5inhibitsangiogenesisinptendeficientprostatecancerbyattenuatingaktactivationandsubsequenthif1aaccumulation |